Search results
Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?
Medscape· 14 hours agoIn February, the US Food and Drug Administration approved irinotecan liposome (Onivyde) as part of a...
US FDA approves Amgen drug for small cell lung cancer
Reuters via AOL· 5 days agoThe U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in...
WTRF Wheeling· 7 hours agoDURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening ...
Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating...
St. Joseph News-Press· 1 day ago(NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines,...
Most cancer treatments are useless for patients with advanced tumors near end of life
UPI· 4 days agoChemotherapies, immunotherapies, targeted therapies and hormone therapies do not improve survival...
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
NBC 17 Raleigh· 14 hours agoHansa Biopharma, "Hansa" (NASDAQ: HNSA) (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant Congress (ATC), the joint annual meeting of ...
A pest of our own making: revealing the true origins of the not-so-German cockroach - EconoTimes
EconoTimes· 11 hours agoGerman cockroaches thrive in buildings all over the world. Theyre one of the most common cockroach...
Social media use linked to higher risk of vaping, smoking
UPI· 4 days agoJust 2% of people who reported no social media use engaged in cigarette smoking, but that rose to...
Spending $75 a month on life insurance means I can stop the cycle of poverty my family's been in for...
Business Insider· 23 hours agoShe bought term life insurance in her 20s after watching family members die without enough money to...
Earnings call: Bio-Path Holdings reports promising Q1 2024 results By Investing.com
Investing.com· 6 days agoBio-Path Holdings (NASDAQ: NASDAQ:BPTH), a biotechnology company focused on developing therapeutic...